DISHMAN PHARMACEUTICALS

INTRODUCTION

Dishman - Global Partnership Solutions
Dishman is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services. The products and services offered span customers’ needs from chemical development to commercial manufacture and supply of active pharmaceutical ingredients. Dishman has a relationship driven business model that improves its customers businesses by providing a range of solutions at locations in Europe, China and India.

Their offer delivers the best of both worlds:
western expertise in speed, flexibility, innovation and rapid material provision
new world expertise in process optimisation, robust large scale processes and secure economic commercial supply.
Their commitment is to deliver cost-competitive technical excellence and to be a reliable partner to our customers, protecting their interests as if they were our own. Dishman is headquartered in Ahmedabad, India and is listed on the Bombay Stock Exchange (BSE). In 2008/09, Dishman had sales of over US$230m. Dishman Pharmaceuticals & Chemicals Ltd. manufactures API intermediates, active pharmaceutical ingredients (APIs), fine chemicals, and quaternary compounds for various pharmaceutical companies. The company has a global presence and exports its products to pharma companies spread across the world.

HISTORY

Dishman Pharmaceuticals was set up in the year 1983 in with its head-office in Ahmedabad. The main purpose of this company was the research and development in the field of life-sciences and pharmaceutical ingredients. The company is presently the world market leader in the pharmaceuticals intermediaries segment. The super quality products, innovative manufacturing, and reasonable prices are the key factors in the success of Dishman Pharmaceuticals. The company also operates in collaboration with the Schütz & Co. of Germany, to form the Schütz Dishman Biotech Private Limited. The tie-up is responsible for produceing chemical compounds like Chlorhexidine Gluconate, Chlorhexidine HCl, Chlorhexidine Base, and Chlorhexidine Acetate solutions.

Corporate Structure of the Dishman Pharmaceuticals

Board of Directors:
Mr. Rajnikant T. Vyas, Chairman & Managing Director
Mr. Janmejay R. Vyas, Managing Director
Mr. Ashok C. Gandhi, Director
Mr. Sanjay S. Majmudar, Director
Mrs. Deohooti J. Vyas, Director
Mr. Yagneshkumar B. Desai, Director

Key Personnels:
Mr. Janmejay R Vyas
Mr. Mark Eugenio
Mr. Curtis Koeppe
Dr. Henk Pluim
Mr. Navin Ajwalia
Mr. Graham Rowe

The R&D activities of the company are categorized into 4 types:
Improvement and optimization of process
Client based pilot studies of new molecules
Process improvement and contract based research of molecules manufactured on contract
In-house applications research for the production of APIs, fine chemicals and other intermediates Intermediaries product manufactured by the company:
Aceprometazine
Aceprometazine Dimaleate
Piperacetazine
Alizapride
Butethamate
Ethylphenacemide
Cisapride
Cisatracurium Besylate

Bulk APIs manufactured by the Dishman Pharmaceuticals:
Lignocaine HCl
Omeprazole Sodium
Tramadol HCl Special chemicals manufactured by the Dishman Pharmaceuticals:
Crown Ethers
Bromopropionic acid
Trimethoxy benzoic acid
Pyridinium Quats manufactured by the company:
Quaternary Ammonium Compounds
Quaternary Phosphonium Compounds
Phosphoranes
Wittig Reagents